Phase 2 Hypersensitivity Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
Food Hypersensitivity
Johns Hopkins University32 enrolled1 locationNCT06934200
Not Yet Recruiting
Phase 2
A pilot study of corticosteroid and antihistamine premedication to prevent hypersensitivity reactions in patients receiving second (or subsequent) line treatment with Carboplatin for treatment of gynaecological malignancy
hypersensitivity reactions in patients receiving carboplatin for gynaecological malignancy
The Royal Women's Hospital46 enrolled2 locationsACTRN12613000646741